Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)

SHE:300653 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	69.55	82.41	134.64	190.96	185.44	168.55
Depreciation & Amortization	21.17	22.31	22.59	20.52	19.1	17.74
Other Amortization	0.48	0.5	0.24	0.43	0.72	0.19
Loss (Gain) From Sale of Assets	-0.04	-	-	-0.02	0.92	-
Asset Writedown & Restructuring Costs	1.05	0.03	0.08	0.12	0.11	0.19
Loss (Gain) From Sale of Investments	-14.33	-13.54	-18.05	-25.27	-7.2	-15.94
Provision & Write-off of Bad Debts	0.26	0.26	0.39	0.05	0.27	0.35
Other Operating Activities	0.01	0.01	-0	0.02	-0	0.01
Change in Accounts Receivable	-1.24	-11.64	15.96	0.27	-5.46	8.18
Change in Inventory	-3.28	5.63	1.53	3.98	-6.72	-10.33
Change in Accounts Payable	5.56	11.55	-5.48	-10.86	2.01	-10.44
Operating Cash Flow	77.81	97.19	151.38	180.48	187.84	166.13
Operating Cash Flow Growth	-33.37%	-35.80%	-16.12%	-3.92%	13.06%	40.28%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-14.41	-9.1	-15.57	-31.88	-56.06	-9.82
Sale of Property, Plant & Equipment	0.23	0.07	-	0.06	0.05	0.18
Investment in Securities	-10.01	-70	91.32	-54.32	-98	-189
Other Investing Activities	14.3	13.87	19.92	15.18	16.17	11.31
Investing Cash Flow	-9.89	-65.17	95.66	-70.95	-137.84	-187.33

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Repurchase of Common Stock	-	-	-49.92	-	-	-
Common Dividends Paid	-49.74	-81.71	-144	-108	-105.6	-30
Other Financing Activities	-	-	-0.01	-0.01	-0	-0.02
Financing Cash Flow	-49.74	-81.71	-193.93	-108.01	-105.6	-30.02

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Cash Flow	18.18	-49.69	53.11	1.52	-55.6	-51.21

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	63.4	88.09	135.81	148.6	131.78	156.31
Free Cash Flow Growth	-38.37%	-35.14%	-8.61%	12.77%	-15.70%	914.68%
Free Cash Flow Margin	18.87%	24.19%	37.39%	35.92%	30.42%	39.06%
Free Cash Flow Per Share	0.36	0.49	0.76	0.82	0.91	0.87
Levered Free Cash Flow	46.76	57.78	82.19	90.49	64.32	82.82
Unlevered Free Cash Flow	46.77	57.79	82.2	90.49	64.33	82.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Interest Paid	-	-	0.01	0.01	0	-
Cash Income Tax Paid	51.37	48.97	35.69	42.9	27.94	38.27
Change in Working Capital	-0.35	5.2	11.5	-6.32	-11.52	-4.96

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error